| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | SR-II-138A | CTRPv2 | pan-cancer | AAC | 0.076 | 0.03 |
| mRNA | Bexarotene | GDSC1000 | pan-cancer | AAC | 0.082 | 0.03 |
| mRNA | Erlotinib | CTRPv2 | pan-cancer | AAC | -0.083 | 0.03 |
| mRNA | LAQ824 | GDSC1000 | pan-cancer | AAC | 0.077 | 0.03 |
| mRNA | ruxolitinib | CTRPv2 | pan-cancer | AAC | 0.082 | 0.03 |
| mRNA | SB52334 | GDSC1000 | pan-cancer | AAC | 0.075 | 0.03 |
| mRNA | BRD-A71883111 | CTRPv2 | pan-cancer | AAC | 0.088 | 0.03 |
| mRNA | PHA-793887 | GDSC1000 | pan-cancer | AAC | 0.064 | 0.03 |
| mRNA | BRD-K13185470 | CTRPv2 | pan-cancer | AAC | -0.16 | 0.03 |
| mRNA | BRD-K01737880 | CTRPv2 | pan-cancer | AAC | 0.27 | 0.03 |